The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy, cellular and molecular determinants of PD-1 checkpoint inhibition in relapsed mesothelioma.
 
Dean Anthony Fennell
Honoraria - Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Inventiva Pharma; Novocure; RS Oncology; targovax
Consulting or Advisory Role - Bristol-Myers Squibb; Inventiva Pharma; Novocure; Roche; Targovax
Speakers' Bureau - BMS; Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals; Bayer; Boehringer Ingelheim (Inst); Bristol Myers Squbb (Inst); Fuji Pharma (Inst); lab21 (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology
 
Sean Ewings
No Relationships to Disclose
 
Kayleigh Hill
No Relationships to Disclose
 
Charlotte Poile
Research Funding - Boehringer Ingelheim
 
Essa Baitei
No Relationships to Disclose
 
Zisen Zhou
No Relationships to Disclose
 
James Harber
No Relationships to Disclose
 
Tamihiro Kamata
No Relationships to Disclose
 
Hongji Yang
No Relationships to Disclose
 
Joanna Dzialo
No Relationships to Disclose
 
Daniel Faulkner
No Relationships to Disclose
 
Christian H.H Ottensmeier
Stock and Other Ownership Interests - NEUVOGEN
Honoraria - Delcath Systems; Transgene
Consulting or Advisory Role - Bristol-Myers Squibb; Delcath Systems; Merck Sharp & Dohme; NEUVOGEN
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - BioNTech (Inst); Bristol-Myers Squibb (Inst); Delcath Systems (Inst); Merck Sharp & Dohme (Inst); PsiOxus Therapeutics (Inst); Scancell (Inst); Touchlight Genetics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Delcath Systems
Other Relationship - Transgene
 
Sarah Danson
No Relationships to Disclose
 
Nicola Steele
No Relationships to Disclose
 
Kim Mallard
No Relationships to Disclose
 
Peter Wells-Jordan
No Relationships to Disclose
 
Catherine Jane Richards
No Relationships to Disclose
 
Min Zhang
Employment - Novogene
 
Jason Lester
No Relationships to Disclose
 
Gareth Owen Griffiths
Honoraria - Abbvie; AstraZeneca
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BionTEch (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Heartflow (Inst); Heartflow (Inst); Jannsenn-Cilag (Inst); Novartis (Inst); Roche (Inst)